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1.  INTRODUCTION: 
 
Radiotherapy plays a vital role in management of breast cancer. In modern day 
radiotherapy, there is emphasis on delivering prescribed doses to the target with 
minimal dose to the adjacent normal tissues. This has become practically feasible with 
advances in radiotherapy planning and treatment delivery. Immobilisation of a patient 
during radiotherapy plays an integral role in the process of accurate delivery of 
radiotherapy. This has not seen much change at par with the changes happening with 
technology. 
The most common immobilisation device used in radiotherapy for breast cancer is a 
breast board.  This is universal for all patients with minimal individualized 
customization. Using a vacuum bag, which allows customized immobilisation is a 
valid alternative. Though Vacuum bag is widely used as an immobilisation device for 
radiotherapy in other sites, its effectiveness as an immobilisation device in breast 
cancer treatment has not established(1). However, its ease of availability and its 
universality makes it a commonly used immobilisation device in breast cancer 
radiotherapy. In our institution, the convention is to use breast board for breast cancer 
radiotherapy. 
In this clinical experiment, we wish to introduce the use of Vacuum bag 
immobilisation in breast cancer radiotherapy and to compare it directly against breast 
board to ascertain its status for use in clinical scenario. 
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2. AIMS: 
1. To compare the set-up uncertainties in whole breast or chest wall radiation therapy 
using two different immobilisation methods: Vacuum bag and supine breast board 
(BB). 
2. To find out the most suitable device among the two devices. 
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3. OBJECTIVES: 
Primary Objective:  
To find the difference in setup displacement from isocenter for the study subjects 
between Vacuum bag and breast board immobilisation.  
Secondary Objectives:  
1. To assess the mean difference in systematic errors and the difference in root 
mean square deviation of random errors between two groups.   
2. Patient’s preference for an immobilisation device, objectively measured using a 
comfort questionnaire.   
3. Mean difference in setup time, in room time and treatment time between two 
immobilisation methods. 
	
	
	
	
	
	
	
	
	
	
 4 
4. REVIEW OF LITERATURE: 
 
4.1 BREAST CANCER PROFILE OF INDIA: 
 
Breast cancer has the highest incidence among cancers across the world. One out 
of four women diagnosed with cancer has breast cancer across the world(2) 
(Table 4.1). In India, it the most frequent cancer among women accounting for 
27% of all newly diagnosed patients (Figure 4.1). 
Table 4.1: Cancer Incidence in Women, World GLOBOCAN 2012(2) 
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Figure 4.1: Cancer Incidence in Women, India  GLOBOCAN 2012(2) 
 
 
For decades, cervical cancer was the most common cancer in women in India and high 
mortality was found in women with cervical cancer than any other cancer. This was 
the scene for almost 4 decades. However, over last ten years breast cancer incidence 
has been rising steadily, and since 2012, breast cancer is the most common cancer in 
women in India. This trend is in part due to an actual decrease in the incidence of 
cervical cancer patients, but also due to the rapid rise in number of patients with breast 
cancer(3). 
In India, the average age of developing a breast cancer has undergone a significant 
shift over last few decades. Breast cancer is now more common in the age group 30 to 
40, which is a very disturbing trend (Figure 4.2). 
The overall 5-year survival for non metastatic breast cancer has increased to almost 
89% in the US according to the 2013 SEER database update(4). This means that, out 
of every 100 women with breast cancer in the US, 89 women are likely to survive for 
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at least 5 years. Such statistics is not available for India. However a rough estimate 
from the population based and hospital based cancer registries is that, this figure is not 
even more than 60%(3). 
Figure 4.2: Age shift in breast cancer in India (3) 
 
 
 
4.2 MANAGEMENT OF BREAST CANCER: AN OVERVIEW: 
 
Management of invasive breast cancer comprises a multimodality approach with 
surgery, chemotherapy, radiation therapy, hormonal therapy and targeted therapy and 
each one of the modality has its role in management of breast cancer.  
 
The primary modality of management with surgery for early invasive breast 
carcinoma has undergone a shift over the years from radical mastectomy to breast 
conservation surgery and sentinel lymph node biopsy. Similarly locally advanced 
breast cancers are made feasible for breast conservation surgery after neoadjuvant 
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chemotherapy following good response to chemotherapy. The adjuvant therapy of 
breast cancer has also improved with the advent of new chemotherapeutic, hormonal 
and targeted agents. Radiation therapy is used in the adjuvant setting in the 
management of breast cancer. 
 
Radiation therapy also has advancements in the technique of delivery from 
conventional through 3D conformal techniques to IMRT and recently accelerated 
partial breast irradiation. Besides the techniques there has also been a transition in the 
dose and fractionation of the radiotherapy delivered.  
 
 
4.3 ROLE OF RADIATION THERAPY IN BREAST CANCER: 
 
It has been established that post operative radiotherapy significantly reduces the loco 
regional recurrence and also improves the local control which indirectly increases the 
cancer specific and overall survival. The importance of local control in breast cancer 
survival cannot be discounted.  
In early breast cancers it is used as adjuvant therapy to deliver whole breast radiation 
followed by boost to the lumpectomy site(5,8). In locally advanced cancers it is used 
to deliver radiation to the chest wall and regional lymph nodes after mastectomy(6,8) 
(Table 4.2, 4.3). The inclusion of regional lymphatic region is based on the number of 
axillary lymph nodes positive for tumour deposits after axillary clearance or on the 
basis of pre-treatment staging.  
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Radiotherapy has evolved from an era, where delivering 50Gy in 25 fractions of 
radiotherapy over 5 weeks was the standard treatment regimen. The UK 
Standardisation of Breast Radiotherapy (START) trials have suggested that lower 
total doses of radiotherapy delivered in fewer, higher dose fractions are as safe and 
effective as the conventional standard regimen(7). The START B fractionation 
proposes a dose of 4005cGy in 15 fractions over 3 weeks, is widely adopted into 
clinical practice in centers across the world in whole breast and chest wall 
radiotherapy.  
Table 4.2: Indications of radiotherapy to breast or chest wall (8) 
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Table 4.3: Indications of radiotherapy regional lymphatics (8) 
 
 
 
LN – Lymph node, ALND – Axillary lymph node dissection, SN – Sentinal node, 
IMC – Internal mammary chain, High risk defined as risk if nodal involvement >15%. 
 
 
4.4   IMMOBILISATION DEVICE FOR BREAST CANCER RADIOTHERAPY: 
 
Radiotherapy is a multi-sitting process that involves delivery of smaller fractions of 
radiation on a daily basis for a longer period to achieve a desired total dose. The main 
goal of radiotherapy is to deliver radiation precisely to the target while avoiding the 
normal tissue at every fraction delivered. The success of radiotherapy delivery will 
depend on how well this goal is achievable. This is possible by planning radiation 
beams in such a way that minimum volume of organs at risk is in the beam path.  
Due to the limited degrees of freedom for directing the radiation beam, the most 
common method to achieve a reproducible patient setup is the use of immobilisation 
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devices. Many systems of patient immobilisation devices have evolved over the years. 
The function of an immobilisation device is to maintain a patient’s body in the same 
reproducible position with minimal mobility during the treatment session. A well-
developed immobilisation system must be comfortable for the patient and simple 
enough to implement.  
In addition, the device must not interfere with the radiation beam. The device must 
possess innate characteristics that would not attenuate the radiation beam or cause 
artifacts. Metal, for example, is not a suitable material for use as an immobilisation 
device. It scatters radiation, produces artifacts, and attenuates a radiation beam 
passing through it. However, metal gives rigid support to the immobilisation device.  
Plastic, a strong, durable and lightweight material is the preferred choice for use in the 
fabrication of the immobilisation device. The attenuation of a radiation beam passing 
through the plastic is also minimal. However, Carbon has the least attenuation 
properties and therefore causes minimal artifacts on imaging. It is also lightweight 
which makes it easy to use. But its use has been limited by its high cost(9). 
Other preferred characteristics of the immobilisation device are its transparency and 
the ability to retain marks. When immobilisation equipment is transparent, it allows 
easy visualization of beam field lights, crosshairs, and distance indicator scale at the 
patient’s skin. The writeable external surface of the material permits markings of the 
lasers and treatment field borders on the immobilisation device.  
Immobilisation in the thorax region is difficult due to respiratory motion. Day-to-day 
reproducibility for the thorax is about 10 mm, based on the assessment of portal and 
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simulation films. The patient’s free breathing greatly increases the target motion 
uncertainty. Hence defining an ideal immobilisation equipment for breast cancer poses 
a major challenge(9). 
Challenges in immobilizing a breast cancer patient: 
1. Breast being a mobile structure, there is a day to day variation in position 
2. Chest movement due to respiration 
3. The position significantly varies with arm position 
4. The shape of chest by nature is curved 
5. Close proximity of lungs and heart 
Barrett-Lennard and Thurston (2008) surveyed radiotherapy centers across various 
countries to identify devices used for immobilisation in breast cancer radiotherapy. 
Nearly 10 different immobilisation devices were identified(1). The survey showed that 
the prone breast board was the most commonly used immobilisation device followed 
by the supine breast board and vacuum bag immobilisation system. 
Even though the prone breast board is the most common immobilisation device used 
world over, its use is limited in the Indian scenario. Among the 100,000 patients 
treated for breast cancer every year in India, only about 1,000 patients are treated with 
breast-conserving treatment. This overall low rate of BCS in Indian patients is a 
reflection of late stage at presentation and only few centers are equipped to provide 
high-quality BCS with all its components including radiation therapy(10).  
The major advantage of prone breast immobilisation is that the breast tissue falls away 
from the organs at risk due to effect of gravity(1). In Indian scenario where the breast 
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conservation rates are relatively low, the use of prone techniques is also very limited. 
Whereas supine techniques allows easier setup and the nodal fields can be matched to 
chest wall fields, which makes radiotherapy planning less complex (1). 
Among the supine techniques breast board and Vacuum bag are the most commonly 
used immobilisation devises.  
Breast board has components like support for arms, elbow and wrist; hip stop; 
adjustable neck support and variable board angles. The board is made of low-density 
foam and carbon fiber. These components ensure that it is simple to use with its 
ability for reproducing each patient’s individual position and does not cause artifacts 
on a CT imaging. This, equipment offers a reliable and highly reproducible patient 
positioning system (Figure 4.3). Knee cushions attached helps in preventing 
longitudinal slip of the patient during treatment(11).  
Figure 4.3: Supine breast board 
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Vacuum bags are made up of rubber coated Macintosh, and are filled with small sized 
Styrofoam balls (Figure 4.4). These components provide air equivalence for the 
incidental treatment beams. The bags are sufficient in size to cover lateral sides of 
body. Air is driven out of the bag to create vacuum inside the bag while the patient 
rests on it. Vacuum hold the position of the Styrofoam balls as displaced by the 
occupancy of patient’s body, which are adjusted according to the body contour of the 
patient. Therefore, the vacuum bags provide a convenient method of creating an 
individual body shape of the patient in their comfortable treatment position(11).  
Figure 4.4: Vacuum bag 
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Various factors like patient’s height, weight, age and thoracic circumference influence 
positional accuracy. However more rigid the device the influence of these factors 
would be lesser(12). Hence, a breast board made of rigid carbon fiber is considered 
reliable and reproducible. Carter et al showed that positional accuracy was better with 
use of a foam cradle in breast radiotherapy(13). Nalder et al compared traditional 
positioning with vacuum bag methods(14). It concluded that vacuum bag allows 
greater abduction and immobilisation of both the arms and thus improving positioning 
accuracy. The systematic and random errors for both the techniques were similar. 
Goldsworthy et al compared single arm abducted on an arm-pole versus both arms 
abducted, confirmed a hypothesis that using double arm abduction increases patient 
stability when a breast board device is employed (15). 
A randomized study compared breast board and vacuum bag immobilisation for 
intensity modulated radiotherapy in breast cancer was conducted by Jassal et al(11). 
Setup errors evaluated from the two immobilisation methods did not differ 
significantly. Thus, a foam cradle or vacuum bag type immobilisation device could be 
a valid alternative. The sample size in this study was small and it was between subject 
comparisons. A between subject comparison may be confounded by individual 
variance and hence may not throw light on the better immobilisation system.  
Hence, various studies that have compared both the immobilisation equipment for 
breast cancer radiotherapy has yielded more confusion than conclusion. So, an ideal 
immobilisation device for breast cancer radiotherapy in supine position is yet to be 
defined.  
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4.5 TECHNIQUES OF RADIATION THERAPY: 
 
4.5.1 TARGETS FOR RADIATION: 
 
After breast conservation surgery: 
• Remnant breast tissue  
• Remnant breast tissue with chest wall (in patients who harbour high risk 
disease to require post-mastectomy radiation had mastectomy been 
done) 
• Regional lymph nodes (if indicated) 
 
After mastectomy: 
• Chest wall 
• Regional lymph nodes 
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4.5.2 WORK FLOW: 
PATIENT POSITION, 
IMMOBILISATION AND
MARKING REFERENCE 
TATTOOS
IMAGING FOR RT 
PLANNING
TARGET AND OAR 
DELINEATION
DEFINITION OF 
CONSTRAINTS
FORWARD PLANNING
OPTIMISATION
PLAN APPROVAL AND 
DATA TRANSFER
SETUP VERIFICATION 
AND TREATMENT
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4.5.3 TECHNIQUES: 
 
Radiation therapy planning and treatment delivery has evolved over several decades. 
In 1925, only kilo voltage x-rays were used to treat superficial tumours. In 1948, using 
synthetic radioactive cobalt for teletherapy eliminated the skin barrier tolerance. The 
linear accelerators that could deliver high energy photons came into existence in 1953 
and use of 2D simulators started in the early 1970’s. 
In the early 1990’s multi-leaf collimators driven by Computerised treatment planning 
system transformed 2D external beam radiotherapy to 3D conformal radiotherapy. 
The improvement in dose calculation techniques, better immobilisation devices, 
intensity modulation and volumated dynamic arc therapy marked the beginning of 
high precision modern radiotherapy era (16). 
4.5.4 CONVENTIONAL RADIOTHERAPY: 
 
Tangents:	The chest wall has been conventionally treated with two tangential beams 
in contrast to AP-PA beams, in order to reduce the dose to lungs and heart. Various 
parameters such as Central Lung Distance (CLD), Maximum Lung Distance (MLD), 
Average Lung Distance (ALD) and Maximal Heart Distance (MHD) are measured 
from a simulator film to predict the volume of lung and heart being irradiated, which 
in turn predicts the probability of radiation induced pneumonitis or cardiac toxicity. A 
CLD of 1.5cm, 2.5cm and 3.5 denotes the involvement of 6%, 16% and 26% of lung 
respectively and a CLD of than 3 cm in left side breast cancer, resulted in irradiation 
of a significant volume of heart. Similarly, grouped ALD (average of superior and 
inferior lung distance) values of < 2 cm, 2-3 cm and > 3 cm show an increasing trend 
 18 
of radiation pneumonitis of 4%, 6% and 14% respectively (17). 
Figure 4.5: Simulation film done during conventional radiotherapy planning 
showing central lung distance and chest wall thickness 
 
 
Figure 4.6: Computerised radiograph showing medial tangential view of a whole 
breast radiotherapy plan with the various parameters of plan evaluation such as 
CLD and MHD marked 
 
CLD (central lung distance) and MHD (maximum heart distance) 
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4.5.5 PRECISION RADIATION THERAPY: 
The concept of CT based volume delineation and planning was introduced in the late 
80’s when a CT extension of X-ray simulator was enabled. This improved field set up 
and dose calculations, though only limited CT slices were available. However, the 
optimal use of 3D based planning became possible when CT simulators replaced X-
ray simulators and dose calculations were no more based on target volume alone but 
also on normal tissue constraints. A conformal therapy plan employs the use of 
multiple tangential beams of varying weightage to produce homogenous coverage of 
target volume as well as sparing of normal tissues.  
 
4.5.5.1 ICRU DEFINITIONS AND VOLUMES: 
 
One of the important factors that have contributed to the success of 3-dimensional 
conformal radiation therapy (3DCRT) is the standardization of nomenclature 
published in the International Commission on Radiation Units and Measurements 
(ICRU) Reports 50 and 62. These reports defined a consistent language and a 
methodology for image-based volumetric treatment planning in which the physician 
specifies the volumes of known tumor (ie, gross tumor volume [GTV]), the volumes 
of suspected microscopic spread (ie, clinical target volume [CTV]), and the marginal 
volumes necessary to account for setup variations and organ and patient motion (i.e., 
planning target volume [PTV]).  
The ICRU first addressed the issue of consistent volume and dose specification in 
radiation therapy with the publication of ICRU Report 29 in 1978. Then ICRU Report 
50 was released in 1993 and a supplement to ICRU 50 report – ICRU 62 was 
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published in 1999. However, there are limitations and practical issues requiring 
compromise when using Reports 50/62 methodology (Figure 4.7, Table 4.4).  
ICRU DEFINITIONS: 
 (1) Complete actual or visible/demonstrable extent and location of the malignant 
growth – Gross tumour volume (GTV). 
(2) A tissue volume that contains a GTV and/or subclinical microscopic malignant 
disease, which has to be eliminated – Clinical target volume (CTV). 
(3) Specific margins that must be added around the CTV to compensate for the 
variations of organ, tumor and patient movements, inaccuracies in beam and patient 
setup, and any other uncertainties – Planning target volume (PTV). 
(4) Treatment volume is defined as the volume enclosed by the isodose surface 
representing the minimal target dose. 
(5) Irradiated volume is defined as the volume that receives a dose considered 
significant in relation to normal tissue tolerance (e.g., 50% isodose surface). 
ICRU Report 62 refined the definition of PTV by splitting PTV margin into 2 margins 
internal margin (IM) and a setup margin (SM).  
(1) IM uncertainties are caused by physiologic variations (e.g., filling of rectum, 
movements caused by respiration, and so on) and are difficult or almost 
impossible to control from a practical viewpoint. 
(2) SM uncertainties are related largely to technical factors that can be dealt with 
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by more accurate setup and immobilisation of the patient and improved 
mechanical stability of the machine.  
 
ICRU Report 62 defines the volume formed by the CTV and the IM as the internal 
target volume (ITV). The report also included a discussion regarding a system of 
classifying organs at risk as serial, parallel, or serial-parallel organs.  
To account for such spatial uncertainties, Report 62 introduced the concept of the 
planning organ at risk volume (PRV), in which a margin is added around the organ at 
risk to compensate for that organ’s geometric uncertainties (18). 
 
Figure 4.7: Schematic illustration of the boundaries of the volumes defined by 
ICRU (19) 
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Table 4.4: Summary of the ICRU Nomenclature for Volumes (1970s to 
Present) (19) 
 
 
4.5.5.2 3 DIMENSIONAL CONFORMAL RADIATION THERAPY: 
The assessment of dose delivered to target volume or normal tissue by conventional 
two-dimensional planning is highly inadequate as it is based on rough estimates. 
Meanwhile, 3 dimensional treatment planning allows more accurate analysis of dose 
to target as well as normal tissue with the aid of dose volume histograms (DVH). In 
this technique, the beam arrangement consisted of two parallel opposing tangential 
beams ensuring the best possible coverage of the breast tissue and minimizing the 
dose to the adjacent critical structures (i.e., ipsilateral lung, contralateral breast, and 
heart) (Figure 4.8). The “isocenter” of the treatment machine is positioned at the 
center point of the midline joining two parallel opposing fields. Physical or dynamic 
wedges are then added to both tangential beams in order to improve the dose 
uniformity to the PTV. Efforts are made to minimize volumes of heart and lung that 
unavoidably get included within the field borders. 
 
 23 
Figure 4.8: An axial section of thorax showing a 3D conformal therapy dose 
distribution 
 
 
The 95% isodose line is covering the target as well as neighboring normal tissue 
(Image from Plato treatment planning system). 
 
4.5.5.3 FIELD-IN-FIELD–FORWARD-PLANNED–IMRT (FiF-FP-IMRT): 
Two open opposed tangential fields are created in this technique, according to the 
geometry defined during simulation to achieve uniform dose distribution to the breast 
volume (adequate coverage to the tumor bed), limiting doses to organs at risk as per 
the constraints defined. The “isocenter” of the treatment machine is positioned at the 
same point as for the 3D-conformal plan. Initially, equal weights are assigned to the 
two open fields, and the corresponding dose distribution is calculated. The the 95% 
dose cloud is viewed in a beam’s eye projection. Subsequently the areas of 
underdosage in the 95% isodose field cloud are picked up.  Then subfields are 
generated manually designed to boost these areas of underdosage. After viewing the 
105% isodose field cloud the shape of subfields are modified to decrease these 
hotspots. This process is termed as manual iteration. The number of subfields usually 
varies from three to four. 6MV photons is selected for the subfields depending on 
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separation of fields. 
Figure 4.9: An axial section of thorax showing a field in field forward planned 
IMRT distribution 
 
Image from Eclipse treatment planning system 
 
4.5.5.4 INVERSELY PLANNED ISOCENTRIC IMRT (IP-IMRT): 
 
The IP-IMRT optimized plans are generated with the same objectives described for 
the FiF-FP-IMRT plan. Multiple beam angles are chosen and multiple beams are 
generated by inverse planning. However, the major contributions would be from the 
two tangential fields as in the FiF-FP-IMRT technique. The major disadvantage of this 
technique is the increased integral dose due to multiple beams and beam angles. Even 
though the coverage may be better, the low dose regions are higher compared to 3D-
CRT and FiF-FP-IMRT plans.  
Compared with 3D-CRT and IP-IMRT, FiF-FP-IMRT proved to be a simple and 
efficient planning technique for breast irradiation in the published literature. It 
provided dosimetric advantages, not just by reducing the size of the hot spot but also 
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improving the coverage of the target volume. In addition, FiF-FP-IMRT requires less 
planning time and easy field placements(20). 
4.5.5.5 IMAGE GUIDED RADIATION THERAPY (IGRT): 
IGRT is defined as the use of advanced imaging modalities during the various steps 
involved in radiotherapy planning and delivery of treatment.  
IGRT involves incorporating functional and/or biological information, to augment 
target and normal tissue delineation during the contouring process; use of in-room 
imaging to adjust for target motion or positional uncertainty (interfractional and 
intrafractional), and, potentially, to adapt treatment to tumor response(21). 
4.5.6 IMAGING BEFORE TREATMENT AND MEASUREMENT OF ERRORS: 
Kilo Voltage CT imaging involves the use of the kilo-voltage X-rays from a source 
separate from the linear accelerator beam but within the treatment room to generate a 
3 dimensional (volumetric) CT image. The CT image is used to verify patient position 
and setup and to determine anatomical changes relevant to treatment. The imaging 
beam in CBCT is shaped like a cone and is captured by a flat panel detector. The 
beam diverges in 2 directions (x and z coordinates) and the imager is positioned to 
catch the entire beam. This is different from a diagnostic CT where the beam is 
projected as a fan shaped beam which only diverges in one direction (x coordinate) on 
to a arc shaped detector. In a cone beam CT, the entire length of the scan is 
incorporated in one rotation, because the beam is allowed to diverge along the z-axis. 
The couch need not move to account for the z coordinate.  
The term field-of-view (FOV) can be simply described as the diameter of the image 
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required to encompass the part of body being imaged. The head and neck can be 
scanned entirely with a small FOV, whereas thoracic imaging requires a larger FOV 
and cannot be covered with standard arrangement of source and imager. As the gantry 
rotates, the half-fan beam covers the entire diameter of the target anatomy. 
The 3 dimensional CBCT images are built from between 300 to 1000 2D projection 
images acquired as the gantry rotates. A computer algorithm converts the 2D image 
collection to a 3D image within a few seconds(21). 
4.5.7 IMPLEMENTATION OF TREATMENT: 
 
After acquiring CBCT image, a clip box is defined on the acquired image to designate 
the volume to be matched. The match parameters and axes to be match should also be 
defined for registration of CBCT images with the images acquired during planning. 
The images are auto-matched and then manually verified for accurate registration. 
Then the matched images are reviewed in different planes (axial, sagittal and coronal) 
(21). 
After registration of the CBCT image with the planning CT images, the setup errors in 
translational axes are noted. The institutional policy decides the thresholds for 
correction of shifts. The shifts are applied and treatment is executed. 
4.5.8 IMPACT OF SETUP TIME IN RADIOTHERAPY: 
 
One of the major factors which has a bearing on a linear accelerator throughput is the 
duration of the entire treatment for each patient (in room time). The duration of entire 
treatment can be split into setup time and treatment time. Setup duration is the time 
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taken from when a patient enters the treatment room to the time when the treatment 
beam is switched on. The treatment time is the time when the beam is switched on and 
the time until she exits the treatment room(22).  
In a country like India where the population linear accelerator ratio is 0.14 per million 
population against the United States which has a population linear accelerator ratio of 
12.31 per million, high throughput is an essential need to cater the needs of patients 
(23). 
4.5.9 PATIENT COMFORT AND SETUP PRECISION: 
 
A comfortable treatment position in radiotherapy promotes patient stability and 
contributes to the best possible patient experience. Patients may move if they do not 
feel comfortable, thereby reducing the accuracy of treatment. It is therefore essential 
when selecting a treatment position to know which is the most comfortable for the 
patient(24). 
To objectively assess patient comfort no relevant validated questionnaire exists in 
literature. Comfort questionnaire has been adapted from the radiotherapy 
immobilisation comfort questionnaire (25). 
4.5.10 STUDY DESIGN: 
 
A clinical experiment can be conducted in many ways. Based on the subjects they are 
conducted on and how they are conducted, they can be broadly classified as within 
subject or a between subject study design. 
In a within subject study each individual is exposed to more than one of the treatments 
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being tested whereas in a between subject study each individual is exposed to only 
one treatment (26) (Table 4.5). 
In a study designed to compare immobilisation devices the two arms have to be 
matched for in multiple parameters. There are numerous confounding factors, which 
are difficult to match in both the arms. The major contributors include age, height, 
weight and many more internal confounders that cannot be accounted for. Hence a 
within subject design study where the both the arms are perfectly matched is an ideal 
study design to be used in this setting.  
However, there may be temporal changes that can happen during the course of 
radiotherapy. To account for this, the treatment on both immobilisation devices is 
alternated daily.  
Table4.5: Study design (within subject vs between subject) 
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4.6  GEOMETRIC UNCERTAINTIES AND VERIFICATION: 
 
A radiation treatment normally consists of one session for planning and multiple 
sessions of irradiation, which comprises the treatment. In the first phase which is 
radiotherapy planning, the patient’s geometry is visualized using CT images. These 
images are the basis for construction of the treatment plan. The intention is to deliver 
this plan in all irradiation sessions. 
The ICRU report 29 considers three sources of geometrical uncertainty that may 
hamper the exact delivery of a plan:  
1. Patient set-up variation 
2. Organ motion and deformation  
3. Machine related errors 
 
Patient set-up errors are due to variations in the daily positioning of the patient on the 
treatment couch. Some session-to-session variation is unavoidable, even though 
several measures are taken to ensure a high reproducibility. These errors in patient 
setup variation can be minimized by using appropriate immobilisation device and in 
room verification imaging.  
Day-to-day tumor motion within the patient can occur due to various reasons, for 
example, variations in arm position. Cardiac action and respiration can result in intra-
fraction tumor movements. Organ motion errors are accounted for by using population 
based internal margins. There margins are usually large as they are often based on 
extremes of organ motion reported. Nevertheless, organ motion is highly variable 
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among individuals. Hence, to reduce internal margins, strategy is to make 
individualized internal margins. For example, a 4D CT scan that can account for 
movement if target during various phases of respiration can be done and treatment 
delivery can also be gated to a particular phase of the breathing cycle where the 
movements of targets is minimal. 
Anatomical changes in the tumour size and shape (deformations) or position may 
occur during the course of radiotherapy treatment. These are not predictable like 
physiological organ motion. To account for organ deformation a margin based 
approach is not practical as predicting the changes is not feasible. Frequent imaging, 
having a threshold for action and adaptive replanning is the solution to account for 
organ deformation.  
With modern radiotherapy equipment, the machine-related geometrical errors, for 
example in beam sizes and gantry angles, are generally considered small compared to 
set-up deviations and organ motion.  
4.6.1 MOTIONS AND ERRORS: 
 
There are six axes of motion. Three are translational in nature and the other 3 are 
rotational. The three translational errors are measured in medio-lateral (lateral), 
supero-inferior (longitudinal) and antero-posterior (vertical) axis. The three rotational 
errors are pitch, roll and yaw are the rotations around lateral, longitudinal and vertical 
axis respectively. The translational errors are represented by x, y and z-axis in 
millimeters. The rotational errors are represented as α, β and γ in degrees.  
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4.6.2 MEASUREMENT OF ERRORS AND CORRECTION STRATEGIES: 
As discussed earlier, once the cone beam CT imaging is acquired and matched with 
the planning CT images, the system superimposes and auto-registers the images. Once 
the registration process is over the co-registered images are manually checked by 
viewing the registered images in 3 planes (i.e. axial, coronal and sagittal).  
After confirming the appropriateness of image registration the couch coordinates are 
shifted to match the isocenter. The magnitude of shifts in millimeters in medio-lateral 
(lateral), supero-inferior (longitudinal) and antero-posterior (vertical) axis are noted. 
The translational errors are corrected by moving the couch coordinates accordingly in 
x, y and z-axis.  
Rotational errors are measured in degree (unit of plane angle). The rotations around 
lateral, longitudinal and vertical axis are noted. The correction of rotational errors 
mandates the use of a 6D couch.  Methods have been described in literature to correct 
rotational errors by moving the gantry, couch and collimator angles. The rotational 
errors in lateral axis(α), longitudinal axis(β) and vertical axis(γ) can be corrected by 
rotating the collimator, gantry and couch angles respectively(27).  But, these 
corrections carry very minimal dosimetric implications, even when rigid 
immobilisation is used where the setup margins are very small. Hence, rotational 
errors are not corrected for in radiotherapy when non-rigid immobilisation devices are 
used. 
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4.6.3 DERIVED ERRORS: 
Setup error: The set-up error is defined as the deviation between actual and expected 
position, normally calculated as a shift in the isocentric position when an image is 
compared against its corresponding reference. 
A group of errors based on the pattern in which they occur can be classified as random 
and systematic errors. An error can be calculated for an individual patient or for a 
population. 
Here are few definitions described in the on target: ensuring geometric accuracy in 
radiotherapy report released by Royal College of Radiologists (28). 
1. Individual mean set-up error: The systematic error (mindividual) is the mean set-up 
error for an individual patient. It is calculated by summing the measured set-up 
error for each imaged fraction (Δ1+ Δ2+ Δ3...) then dividing by the number of 
imaged fractions (n).  
mindividual =(Δ1+Δ2+Δ3 +......+Δn)/ n 
2. Overall population mean set-up error: The overall mean set-up error (Mpop) is the 
overall mean for the analysed patient group and should ideally be zero. Departures 
from zero indicate an underlying error common to this patient group and requires 
investigation. This parameter is a strong indicator of the efficacy of any given 
treatment technique and is often omitted.  
The means for each individual patient (m1, m2, m3...) being summed and the total 
divided through by the number of patients in the analysed group (P).  
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Mpop = (m1+ m2+ m3 +......+ mp)/ P 
3. Population systematic error: The systematic error for the population (∑set-up) is 
defined as the standard deviation (spread) of the individual mean set-up errors 
about the overall population mean (Mpop).  
∑2 = [(m1 – Mpop)2 + (m2 – Mpop)2+ (m3 – Mpop)2+....+ (mn – Mpop)2]/(P-1) 
4. Individual random error: For each individual, the interfractional random (daily) 
set-up error (σindividual) is the standard deviation of the set-up errors around the 
corresponding mean individual value. It is calculated by summing the squares of 
the differences between the mean and set-up error from each image in turn.  
(σindivudual)2 = [(Δ1 – m)2 + (Δ2 – m)2+ (Δ3 – m)2+....+ (Δn – m)2]/n 
5. Population random error : The population random error (σset-up) is the mean of all 
the individual random errors (σ1, σ2, σ3....). This equation assumes that the number 
of images acquired per patient is identical or that the likely differences will have 
minimal effect on the final result.  
σset-up = (σ1 + σ2 + σ3 +....+σp)/p 
 
4.6.4 MARGIN RECIPES: 
Margin recipes are formulas that are used to calculate the setup planning target 
volume (PTV) margins (Figure 4.10). Van Herk and Stroom’s formula is used in 
centers across the world to derive institution specific PTV margins.  
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Figure 4.10: Clinical target volume and Planning target volume in an ideal 
scenario 
 
 
 
The population systematic error and population random errors form the basis for 
deriving PTV margins. A systematic error if introduced into the treatment beyond the 
PTV margin accounted for; there is a consistent under dosage to a part of clinical 
target volume (CTV). Hence, a systematic error shifts the cumulative dose distribution 
(Figure 4.11). 
Figure 4.11: A systematic error shifts the cumulative dose distribution 
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When the error is random, different parts of CTV is under dosed on a day-to-day 
basis. Hence, a random error blurs the cumulative dose distribution (Figure 4.12). 
Figure 4.12: A random error blurs the cumulative dose distribution 
 
 
 
 
Van Herk’s Formula: (29) 
This has been calculated with an assumption that minimum dose to CTV is 95% for 
90% of patients.  
PTV = 2.5 ∑ + 0.7 σ 
∑ = Population systematic error and σ = Population random error 
 
Stroom’s Formula: (30) 
This formula has been derived with an assumption that 95% dose to on average 99% 
of CTV.  
PTV = 2 ∑ + 0.7 σ 
∑ = Population systematic error and σ = Population random error 
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Several population-based margin calculation recipes have been proposed (31).  
All the PTV margin recipes can be summed up into the following equation.  
CTV to PTV margin = a∑+ bσ + c (28) 
 
∑ = Population systematic error, σ = Population random error and and a, b and c are 
constants. The constant c is included to account for parameters that affect the margin 
in a linear manner, such as breathing. The two constants a and b characterise the 
relative contributions of the systematic and random components. Typically ‘a’ is 3–4 
times greater than ‘b’ and ∑ is generally much larger than σ indicating that the key 
contributor to the margin is the combined systematic error. 
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5.  MATERIALS AND METHODS: 
5.1 STUDY DESIGN: 
Patients requiring conformal radiation 
therapy to breast or chest wall
Information sheet and informed consent in 
language which patient can read and 
understand
Patient accrual
• Immobilise in supine position on a Breast board and mark 
reference points
• Match the same reference points on a vacloc immobilisation
• Two sets of CT images are acquired ( set with vacloc 
immobilisation and other set with breast board immobilisation)
• A standard field in field IMRT plan is generated on the breast 
board CT and approved for treatment
• The approved plan is reproduced on to the vacloc CT and a 
new plan is generated on the dataset. 
• Both plans are matched independently and approved for 
treatment.
• The first patient in this study will start the treatment with a breast board and 
the next patient with a vacloc.
•  This pattern would be followed for all patients getting recruited subsequently. 
• Patient positioning was alternated daily, thus patients were treated for half of 
the fractions with breast board and half of the fractions with vacloc
• Cone beam CT verification and translational corrections 
recorded in 3 principal axes.
• Systematic error corrections are applied on Day 4
• Comfort questionnaire to be filled by patient on Day 14 and 
Day 15 for respective immobilisation device
• Setup time and treatment time is recorded on all days
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5.2 SAMPLE SIZE: 
 
Evaluation of patients treated with breast board showed that that the mean 
displacements ranged between 5 to 9 mm. The calculated standard deviation was 2.3. 
Assuming a standard deviation of 3 and considering 3mm as delta with an alpha error 
of 0.05 and beta error of 0.8 the calculated sample size was 10.  
We wished to recruit 20 patients to account for possible drop outs and loss of data. 
However only 16 patients were only recruited with in the stipulated time period.  
 
 
5.3 INCLUSION / EXCLUSION CRITERIA: 
 
1)  Patients requiring conformal radiotherapy to breast or chest wall using field in 
field tangential forward planned IMRT were recruited in to the trial. 
2) Willingness to participate in the trial   
3) Patients for whom equivalent plans could not be generated for vacuum bag and 
breast board immobilisation, were further excluded from participation in the 
trial and they were treated on the immobilisation device of choice by the 
clinician outside the trial. 
 
5.4  RADIATION THERAPY PLANNING: 
 
5.4.1 PATIENT POSITIONING: 
1) Patients were reviewed in the simulator room for making the necessary 
immobilisation equipment. 
2) The patients were placed in a supine position over the breast board. 
3) A fluoroscopic screening was done and the patients were adjusted to align the 
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vertebrae linear, so that the immobilisation position would be reproducible. 
4) The arms were abducted and stabilized in a comfortable position over the arm 
rest.  
5) The parameters required for reproducibility of the patient in the same position 
were documented on the setup sheet. The target region for treatment will be 
marked on the patient’s body. 
6) With the help of lasers in the room, 3 reference points were tattooed on the 
patient’s body. 
7) Then the patients were repositioned on a inflated vacuum immobilisation 
equipment (Vacuum bag). 
8) The patients were made to lie in comfortable supine position with arms 
abducted and neck in a relaxed position with slight extension 
9) Again, a fluoroscopic screening was done to check position. Then the Vacuum 
bag was molded to the patient’s body by deflating it. We also ensured that the 
position on the Vacuum bag aligns the three tattoo marks on the patient with 
the room lasers. 
10) The two lateral tattoos were matched. 
11) However, if the anterior tattoo could not be matched for all patients, a new 
tattoo for the vacuum bag immobilisation equipment was marked on the 
patient’s body. 
 
 
5.4.2 CT SIMULATION: 
1) The patients were taken to a CT machine with a flat couch.  
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2) The patients were positioned on a breast board immobilisation equipment first 
and reference tattoos on the patients body were matched with the lasers in the 
CT machine. 
3) Lead markers were placed on the reference points marked on the skin on the 
patient’s body so as to determine the CT isocenter during the planning process. 
4) The target region on the patient body (marked already) were also marked by 
lead wires.  
5) A topograph was taken and the position is verified. 
6) 80ml of ionic contrast was given and CT images were acquired in the venous 
phase. 
7) Then the patients were positioned on a VACUUM BAG and reference tattoos 
were matched. 
8) Another set of CT images were acquired after verifying the position with a 
topograph. 
9) The images were acquired in DICOM format and they were sent to the Eclipse 
treatment planning system for treatment planning.   
5.4.3 TARGET VOLUME DELINEATION: 
1)  Breast CTV:  Considers referenced clinical breast at time of CTV, the apparent 
CT glandular breast tissue and the lumpectomy CTV 	
2) Lumpectomy GTV: Includes seroma and surgical clips when  present	
3) Chest wall CTV: Considers referenced clinical chest wall at time of CT and 
contralateral breast  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4) While contouring the chest wall or the breast the lead wires marked over the 
target region were used as clinical reference. 
5) Ipsilateral supraclavicular nodes and/or axilla were contoured and included in 
CTV if indicated. 
6) The target volumes and organs at risk were delineated by the same radiation 
oncologist on both the sets of CT images. 
7) The volumes were approved by the radiation oncologist and sent for treatment 
planning.   
5.4.4 TREATMENT PLANNING: 
1) Field in field intensity modulated radiation therapy technique was used for 
treatment planning. 
2) A standard plan was generated on the breast board CT and approved by 
radiation oncologist. 
3) The approved plan was reproduced on to the Vacuum bag CT and a new plan 
was generated on the dataset. 
4) This plan was again reviewed for match with the previous plan by the radiation 
oncologist and independently approved for treatment. 
5) Both plans were sent for treatment. 
6) Treatment was initiated after the routine quality assurance check.   
5.5     TREATMENT DELIVERY: 
1) 6MV Photons was used for treatment.   
2) Chest wall – Single phase   
3) Whole breast – single phases followed by boost outside of trial setting. 
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4) A bolus was also used to for adequate coverage of the target volumes. 
5) The first patient in this study started the treatment with a breast board and the 
next patient started the treatment with	a Vacuum bag. 
6) This pattern was followed for all patients being recruited subsequently. This 
ensured that there is equal number of translational corrections recorded with 
both immobilisation devices. 
7) Cone beam CT was done and it was registered with the corresponding CT 
images with the approved plan. 
8) The matching was done on the basis of targets defined for treatment. 
9) The system calculates necessary table shifts in 3 dimensions. They were 
verified manually (online) and corrections were applied prior to treatment. 
10) Translational corrections were recorded for all patients on the three principal 
axes (lateral, vertical, longitudinal) on all days of treatment. 
11) Before the treatment beam was switched on the light fields were checked on 
the patient’s body for both immobilisation equipment on the first day of 
treatment for the respective device. 
12) On last treatment with each immobilisation device, a comfort questionnaire 
was given to each patient to assess the patient’s comfort with respective 
immobilisation device. 
5.6 TREATMENT TIME: 
1) The time needed for patient setup and the lengths of the whole treatment slot 
was recorded daily – in room time. 
2) The duration of setup is the time when the patient entered the treatment room 
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until the start of the treatment beam.  
3) The length of the treatment slot is the time when the patient entered the 
treatment room until she exits the treatment room.  
5.7   OBJECTIVE ASSESSMENT OF PATIENT COMFORT: 
1) All patients were requested to fill a comfort questionnaire after completion of 
treatment on Day 14 and Day 15 to objectively assess patient comfort. The 
questionnaire has been adapted from the radiotherapy immobilisation comfort 
questionnaire. 
2) Patients’ preference for immobilisation equipment was also recorded. 
5.8 STATISTICAL ANALYSIS: 
From the translational errors recorded in three principal axes systematic and random 
errors were calculated. Median systematic error and mean random error was derived 
for both groups. A non parametric test was used to compare the median systematic 
error in both groups and parametric test was used to compare the mean random error. 
Paired t test was used to compare the differences in setup duration, treatment time and 
in room time.  
 
 
 
 
 
 
 
6. RESULTS AND ANALYSIS: 
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6.1 OVERVIEW OF PATIENTS RECRUITED IN THE STUDY: 
From October 2015 to August 2016, 25 patients were treated with adjuvant conformal 
radiotherapy for breast cancer. Among the 25 patients screened, 16 patients meeting 
the eligibility criteria and were enrolled in the study as shown in Table 6.1.  
Table 6.1: Patient recruitment 
Total number of patients screened 25 
Patients who were recruited in to the 
study  
16 
Patients not recruited  9 
Not willing to participate in the study – 3 
Distribution not similar in both plans – 2 
Inadequate axillary coverage in vacuum 
bag plans – 4  
 
6.2 PATIENT CHARACTERISTICS: 
Among subjects included in the study 44% were in the age group of 46 – 55 years as 
shown in the table below. The median age of the patients in the study group was 47. 
The age group ranged from 28 to 74 years. There were nine patients with right sided 
breast cancer and 7 patients with left sided breast cancer. The median height of the 
study population was 153.5 cm and height ranged from 146 to 164 cm as shown in the 
table. The median weight of the study subjects was 65 kg and weight ranged from 44 
to 81kg as shown in the table. Seven patients had normal body mass index, 5 were 
over weight and 4 were obese among the study subjects. The thoracic circumference 
ranged from 78 to 111 cm with the median at 95 cm. Six patients had early breast 
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cancer, 6 had locally advanced breast cancer and the stage was unknown in 4 patients 
as they reported after surgery elsewhere (Table 6.2). 
Table 6.2: Patient characteristics 
Variables Groups Frequency Percentage 
Age 25 to 35 2 13 
36 to 45 4 25 
46 to 55 7 44 
>55 3 18 
Laterality Right 9 56 
Left 7 44 
Body mass index 
(BMI) 
Mean 26.90 - 
Patients with 
normal BMI 
7 44 
Patients 
Overweight 
5 31 
Patients Obese 4 25 
Height Median 153.5 cm - 
Range 146 to 164 cm - 
Weight Median 65 kg - 
Range 44 to 81 kg - 
Thoracic 
circumference 
Median 95 cm - 
Range 78 cm to 111cm - 
Stage I 1 6 
II 5 31 
III 6 38 
Unknown 4 25 
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6.3 TREATMENT CHARACTERISTICS: 
Nine patients among the sixteen had modified radical mastectomy (MRM) and 7 had 
breast conservation surgery (BCS). Among the seven patients who underwent BCS, 3 
patients received radiation therapy to supraclavicular region. All 9 patients who 
underwent MRM received radiation therapy to chest wall and supraclavicular region. 
Seven patients received neoadjuvant chemotherapy, 5 received adjuvant, 3 patients 
received hormonal therapy and 1 patient received neoadjuvant chemotherapy followed 
by surgery and adjuvant chemotherapy (Table 6.3).  
Table 6.3: Treatment characteristics 
Variables Groups Frequency Percentage 
Type of surgery MRM 9 56 
BCS 7 44 
Target volumes Whole breast alone 4 25 
Whole breast and supraclavicular 
area 
3 19 
Chest wall and supraclavicular 
area 
9 56 
Chemotherapy Neoadjuvant 7 44 
Adjuvant 5 31 
Both 1 6 
No chemotherapy 3 19 
(BCS – Breast conservation surgery, MRM – Modified radical mastectomy) 
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6.4 TRANSLATIONAL ERRORS: 
A total of 239 CBCT acquisitions were analyzed among 16 patients. 117 translational 
errors in lateral, longitudinal and vertical axis with breast board immobilisation and 
122 with vacuum bag immobilisation were recorded.  
The median of individual median translational errors observed with breast board 
immobilisation were 0.075, 0.075 and -0.25 cm in lateral, vertical and longitudinal 
axis respectively. Similarly, median of individual median translational errors observed 
with vacuum bag immobilisation were -0.025, -0.05 and -0.125 cm in lateral, vertical 
and longitudinal axis respectively. The median in both groups for all three axes were 
close to zero as depicted by the peak of the normal curve in the frequency histograms. 
The mean ranged from -0.1cm to 0.14 cm with a standard deviation ranging from 
0.511 to 0.685 cm in three principal axes for both groups (Figure 6.1). 
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Figure 6.1: Frequency histograms depicting all errors recorded in three principal 
axes across breast board and vacuum bag immobilisation devices 
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The group mean (m) errors were -0.05 cm, -0.1 cm, 0.14 cm in lateral, vertical and 
longitudinal axis respectively with breast board immobilisation. Similarly, the group 
mean (m) errors were 0.03 cm, -0.08 cm, -0.07 cm in lateral, vertical and longitudinal 
axis respectively with vacuum bag immobilisation (Table 6.4). 
Table 6.4: Group mean of translational errors in three principal axes with breast 
board and vacuum bag immobilisation. 
Immobilisation Axis Group mean (m) 
in cm 
 
Breast Board (BB) 
Lateral (x) -0.05 
Vertical (y) -0.1 
Longitudinal (z) 0.14 
 
Vacuum bag (VC) 
Lateral (x) 0.03  
Vertical (y) -0.08 
Longitudinal (z) -0.07 
 
 
6.4.1 SYSTEMATIC ERRORS: 
The median systematic error in the lateral, longitudinal and vertical axes were 0.2cm, 
0.3cm and 0.3cm for breast board and 0.3cm, 0.3cm and 0.2cm for vacuum bag 
immobilisation respectively. A non parametric test was used to statistically correlate 
the difference in median systematic error between two immobilisation devices and 
median values did not significantly differ across both immobilisation devices (Table 
6.5). 
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Table 6.5: Non parametric test analysis: To compare the median systematic error 
shifts for 3 principal axes across breast board and vacuum bag immobilisation  
 
(IQR – Inter Quartile Range) 
 
Table 6.6: Correlation between median systematic error and body mass index in 
3 principal axes across both groups 
Immobilisation Axis Normal BMI Overweight Obese 
 
Breast board 
Lateral (x) 0.1 -0.1 -0.15 
Longitudinal (z) 0 0.2 0.05 
Vertical (y) -0.3 0 0.1 
 
Vacuum bag  
Lateral (x) -0.3 0.3 0.1 
Longitudinal (z) 0.2 0.1 -0.55 
Vertical (y) -0.2 -0.2 0.05 
 
The population systematic error for the breast board was 0.28 cm, 0.47 cm and 0.31 
cm in lateral, longitudinal and vertical axis respectively. Similarly, the population 
systematic error for the vacuum bag group was 0.39 cm, 0.44 cm and 0.28 cm in 
lateral, longitudinal and vertical axis respectively. Correlation between median 
systematic error and body mass index did not follow any pattern in the magnitude and 
direction of errors as shown in Table 6.6. Figures 6.2, 6.3 and 6.4 shows individual 
systematic errors in lateral, longitudinal and vertical axis for breast board and vacuum 
bag immobilisation. 
 
 
Variable Group n Median(IQR) Min. Max. p-value 
Systematic 
Error lateral 
Breast board 16  0.2,(0.1,0.4) 0 0.6 0.10 
Vacuum bag 0.3,(0.2,0.5) 0 0.7 
Systematic error 
longitudinal 
Breast board 16  0.3,(0.2,0.4) 0 1.3 0.72 
Vacuum bag 0.3,(0.2,0.5) 0 0.9 
Systematic error 
vertical 
Breast board 16 0.3,(0.2,0.4) 0 0.6 0.47 
Vacuum bag 0.2,(0.1,0.3) 0 0.7 
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Figure 6.2: Bar diagram depicting systematic error shifts in lateral axis for 
breast board and vacuum bag immobilisation. 
 
 
 
 
Figure 6.3: Bar diagram depicting systematic error shifts in longitudinal 
axis for breast board and vacuum bag immobilisation  
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Figure 6.4: Bar diagram depicting systematic error shifts in vertical axis for 
breast board and vacuum bag immobilisation. 
 
 
 
 
6.4.2 RANDOM ERRORS: 
The mean random error in the lateral, longitudinal and vertical axes was 0.43cm, 
0.51cm and 0.46cm respectively for breast board. Similarly, the mean random error in 
the lateral, longitudinal and vertical axes was 0.41cm, 0.36cm and 0.44cm 
respectively for vacuum bag immobilisation. A parametric test was used to correlate 
the difference in mean random error between two immobilisation devices and there 
was a statistically significant difference observed only in the longitudinal axis (0.51 vs 
0.36 cm, p-value = 0.03). There was no significant difference in mean random errors 
in lateral and vertical axis as shown in the Table 6.7. 
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Table 6.7: Parametric test analysis: To compare the median systematic error 
shifts for 3 principal axes across breast board and vacuum bag immobilisation 
 
(SD – Standard deviation) 
 
Table 6.8: Correlation between mean random error and body mass index in 3 
principal axes across both groups 
 
 
The magnitude of mean random errors was higher in obese patients. However, there 
was no major difference in magnitude of among the overweight and patients with 
normal body mass index. 
The longitudinal shifts were lesser with the use of a vacuum bag immobilisation 
compared to a breast board. The magnitude of difference in longitudinal shifts was 
higher among overweight and obese patients (Table 6.8). 
Variable Group n Mean(SD) Min. Max. P-value 
Random 
error lateral 
Breast board 16  0.43 (0.19) 0.2 0.9 0.68 
Vacuum bag 0.41(0.21) 0.1 0.9 
Random error 
longitudinal 
Breast board 16  0.51 (0.23) 0.3 1.2 0.03 
Vacuum bag 0.36(0.13) 0.1 0.5 
Random error 
vertical 
Breast board 16 0.46(0.18) 0.2 0.8 0.80 
Vacuum bag 0.44 (0.18) 0.2 0.8 
Immobilisation Axis Normal BMI Overweight Obese 
 
Breast board 
Lateral (x) 0.35 0.4 0.6 
Longitudinal (z) 0.38 0.52 0.72 
Vertical (y) 0.37 0.46 0.6 
 
Vacuum bag  
Lateral (x) 0.4 0.3 0.55 
Longitudinal (z) 0.31 0.28 0.45 
Vertical (y) 0.34 0.46 0.6 
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Figure 6.5: Bar diagram depicting random error shifts in lateral axis for breast board 
and vacuum bag immobilisation  
 
 
 
 
Figure 6.6: Bar diagram depicting random error shifts in longitudinal axis for 
breast board and vacuum bag immobilisation. 
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Figure 6.7: Bar diagram depicting random error shifts in vertical axis for breast 
board and vacuum bag immobilisation. 
 
 
 
Figures 6.5, 6.6 and 6.7 shows individual random errors in lateral, longitudinal and 
vertical axis respectively for breast board and vacuum bag immobilisation. 
The median of Mean Euclidean Distance was 0.95 (IQR 0.7 to 1.17) for the breast 
board group and 0.75 (IQR 0.63 to 0.98) for the vacuum bag group as depicted by the 
histograms (Figure 6.8). 
The population random error for the breast board was 0.43 cm, 0.51 cm and 0.45 cm 
in lateral, longitudinal and vertical axis respectively. Similarly, population random 
error for the vacuum bag group was 0.40 cm, 0.35 cm and 0.44 cm in lateral, 
longitudinal and vertical axis respectively.  
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Figure 6.8: Histogram depicting mean and median of Mean Euclidean Distance for 
breast board and vacuum bag immobilisation 
 
      Breast board                                                                 Vacuum bag 
 
 
 
6.5 PATIENT COMFORT: 
 
Eleven patients preferred to use a vacuum bag immobilisation and 5 preferred to use a 
breast board on a binary question. Objective assessment of patient’s preference using 
the questionnaire, showed that 10 patients preferred to use a vacuum bag 
immobilisation and 4 preferred to use a breast board. Two patients preference was 
equivocal (Table 6.9). 
 
Ten patients favored use of a vacuum bag immobilisation on objective assessment and 
with a binary answer favoring vacuum bag. Four patients favored use of a breast board 
on objective assessment and and with a binary answer favoring breast board. Among 
the two patients who had equivocal response on objective assessment, 1 favored use 
of a vacuum bag and other favored a breast board on the binary question. 
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Table 6.9: Patient’s preference for immobilisation device and objective 
assessment of patient’s preference 
 
(VC – favors vacuum bag, BB – favors breast board, NR – no response, EQ – 
equivocal response) 
 
 
6.6 TREATMENT TIME: 
 
The time recordings noted were 157 from 240 treatment sessions. There were 81 time 
recordings with the use of a breast board and 76 with a vacuum bag immobilisation.   
 
The mean setup duration for breast board immobilisation and vacuum bag 
immobilisation were 8.2 minutes and 7.22 minutes respectively. Paired t test 
interpretation showed statistically significant difference in setup duration (Table 6.10). 
 
Patient Question 1 
My body 
feels 
relaxed 
Question 2 
I feel 
comfortable 
in this 
position 
Question 3 
Pain in my 
shoulder 
bothers me 
Question 4 
It feels 
embarrassing 
to lie in this 
position 
Question 5 
My back 
muscles 
ache when I 
lie on 
Objective 
Preference 
Subjective 
Preference 
1 VC EQ VC VC VC VC VC 
2 NR VC EQ EQ EQ VC VC 
3 EQ BB EQ EQ BB BB BB 
4 VC EQ VC NR VC VC VC 
5 VC VC EQ EQ EQ VC VC 
6 BB BB BB EQ BB BB BB 
7 VC VC VC EQ VC VC VC 
8 VC VC VC VC BB VC VC 
9 EQ EQ BB VC EQ EQ BB 
10 EQ EQ EQ BB EQ BB BB 
11 VC VC VC EQ BB VC VC 
12 BB BB BB BB BB BB BB 
13 VC VC EQ VC VC VC VC 
14 EQ EQ EQ EQ EQ EQ VC 
15 EQ EQ VC EQ EQ BB VC 
16 VC VC VC BB BB VC VC 
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The mean treatment duration for breast board immobilisation and vacuum bag 
immobilisation was 7.81 minutes and 7.4 minutes respectively.  
 
The mean in-room time was 16.02 minutes and 14.63 minutes for breast board and 
vacuum bag immobilisation respectively. There was no statistical significance 
observed between the two groups in treatment duration and in-room time (Table 6.10). 
 
Table 6.10: Mean setup duration, treatment duration and in-room time observed 
between breast board and vacuum bag group 
 
 
 
 
6.7 EASE OF PLANNING: 
 
The duration taken for creating a treatment plan was similar for both the groups. The 
physicists were comfortable to plan with a breast board immobilisation compared to a 
vacuum bag immobilisation.  However, it was easier to attain adequate target dose 
coverage with optimal constraints with a vacuum bag plan compared to a breast board 
plan.  
 
6.8 QUALITY OF PLANS: 
 
There was no difference in the quality of plans generated between the two groups 
reported by the radiation oncologist. 
Variable Immobilisation 
Device 
Mean Standard 
deviation 
95% confidence 
interval 
P-value 
Setup 
duration 
Breast board 8.203 2.166 7.048 to 9.357 0.03 
Vacuum bag 7.226 1.220 6.576 to 7.876 
Treatment 
duration 
Breast board 7.819 1.754 6.884 to 8.754 0.38 
Vacuum bag 7.409 1.907 6.392 to 8.425 
In-room 
time 
Breast board 16.02 3.163 14.339 to 17.710 0.05 
Vacuum bag 14.635 2.585 13.257 to 16.013 
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7. DISCUSSION: 
 
Precision radiotherapy warrants careful verification of setup before delivery of 
radiation. Errors in precision radiotherapy can cause serious consequences affecting 
long term and short term outcome of treatment. Positioning and immobilisation of a 
patient during radiotherapy plays a crucial role. Hence, in precision radiotherapy for 
breast cancer treatment, the patient alignment aided by an appropriate immobilisation 
is of prime importance(32). In our study we intended to compare the setup 
uncertainties between use of a breast board and vacuum bag in radiotherapy for breast 
cancer. A within subject study design was chosen to match various confounding 
factors between the two groups. Patient comfort and treatment time were also 
compared across both immobilisation devices. 
 
The stipulated duration for this study was 12 months with a sample size of 20, 
considering delta as 3mm. Patients requiring radiation therapy to the axilla could not 
be planned on a vacuum bag immobilisation and there was inhomogeneous dose 
distribution across both plans resulting in patients getting excluded out of the study. 
Hence the desired sample size was not achieved during the stipulated time period. All 
patients except one completed the treatment without any break during the course of 
radiotherapy.  
 
7.1 SETUP PRECISION: 
 
The magnitude of breast motion for radiotherapy treatment varies from patient to 
patient and numerous variables contribute to errors during radiotherapy. Kubo et al 
reported the range of breast motion between 5-7mm during quiet breathing(33).  
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In this study the population systematic and random errors ranged from 0.28 to 0.51cm 
which is similar to the studies published in literature. Earlier studies reported 
systematic and random error shifts less than 3mm(34). However, these studies were 
conducted on 2 dimensional digitally reconstructed radiographs matched with imaging 
from electronic portal imaging device from the treatment machine. The magnitude of 
errors were lower as these imaging modalities allowed bone to bone matching. In the 
CBCT era which allows for soft tissue matching the errors tend to show a greater 
magnitude.  
Our study demonstrated that the magnitude of mean random error was higher among 
obese patients in both the groups. Similar findings have also published in literature 
comparing body habitus and setup uncertainties in patients with endometrial cancer. 
Lin et al showed that the daily shifts, systematic error and the random error were 
greatest among obese patients (35). 
Among the mean random error shifts observed the magnitude of shifts were lesser 
with the use of a vacuum bag in obese and overweight patient compared to a breast 
board immobilisation. 
Various studies have published population systematic and random errors for supine 
position radiotherapy in breast cancer where image verification was done with cone 
beam computed tomography (CBCT). The systematic and random errors were small, 
not exceeding 5mm in the studies reported in literature(36). There was no correlation 
between the magnitude of systematic and random errors among the studies reported in 
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literature.  Some studies reported a larger systematic error and a smaller random error, 
whereas a few studies showed vise-versa trend(36). 
In our study the magnitude of random errors was higher in the longitudinal axis as 
compared to the lateral and vertical axis. This error is probably caused by day to day 
variations in arm position. While positioning a patient for treatment, the technologists 
aligns the anteriorly placed tattoo to the central axis of the field and also the laterally 
placed tattoos are matched with the room lasers. If the patient is setup on a breast 
board, all these tattoo marks are placed on the patient. Whereas, when using a vacuum 
bag the lateral alignment of patient is based on markings on the sides of a vacuum 
bag. When a patient is positioned on a breast board, to match for the skin tattoos 
laterally the arm position may vary. Due to these the skin stretches differently each 
day contributing to the longitudinal shift. In case of vacuum bag, since the lateral 
markings are not placed on skin, longitudinal shifts tend to be of a lesser magnitude as 
shown in this study. Furthermore, a breast board is inclined and there is a chance of 
sliding down when positioned, whereas, a vacuum bag does not have any inclination 
and hence lesser longitudinal shifts. 
Among the parameters measured to determine setup uncertainty, vacuum bag 
immobilisation demonstrated equivalence to use of a breast board. Hence, as far as 
interfraction variability in set up is considered, vacuum bag immobilisation was 
observed to be similar to breast board for breast cancer radiotherapy. 
 
7.2 PATIENT COMFORT: 
Patient comfort was assessed and patients preferred to use a vacuum bag compared to 
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a breast board. Patient reported shoulder pain and back ache was higher with the use 
of a breast board. Patients preferring a breast board reported lack of arm support in 
vacuum bag immobilisation leads to pain and discomfort in the shoulder. To our 
knowledge, there are no other studies in literature reporting patient comfort compared 
across a vacuum bag and breast board. 
7.3 TREATMENT TIME: 
In this study the mean in-room duration was 16.02 minutes in the breast board group 
and 14.6 minutes in the vacuum bag group. The mean in-room time for supine 
radiotherapy using a breast board reported in literature was 19.4 minutes(37). In this 
study, the respiratory movements were also analysed during treatment which could 
have contributed to higher in room time. However, the setup duration was 
significantly lesser in the vacuum bag group compared to the breast board group.  
7.4 EASE OF PLANNING AND QUALITY OF PLANS: 
Patients requiring radiation to axilla could not be planned on a vacuum bag 
immobilisation in view of increased convexity of the target area and hence the lung 
doses were higher with a vacuum bag plan compared to a breast board plan. The 
physicist was comfortable to plan with a breast board than with a vacuum bag as the 
breast board plan required lesser subfields than a vacuum bag plan. They were able to 
achieve target volume coverage and optimal doses to organs at risk with a vacuum bag 
plan compared to a breast board plan.  
 
In the initial phase of the study the breast board plans were easier to generate, 
whereas, in the latter part of the study generation of vacuum bag plans was also of 
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equal ease. In our institution, use of breast board was standard for breast cancer 
radiotherapy and planning on vacuum bag for breast cancer was only patients on this 
study. There is also an inherent bias as the study protocol warrants planning on a 
breast board first and then modify the generated plan for a vacuum bag immobilisation 
which could make our physicist feel that planning on a breast board plan was easier.  
 
To our knowledge there are no studies in literature comparing ease of planning across 
breast board and vacuum bag immobilisation for breast cancer radiotherapy. 
 
8. LIMITATIONS: 
 
1. The desired sample size for this study was not achieved within the stipulated 
time period.  
2. The questionnaire used for objective assessment of comfort was not a validated 
questionnaire. 
3. This study looks only at setup precision, patient comfort and treatment time. 
Dosimetric evaluation of plans, magnitude of respiratory movements 
compared across both immobilisation devices were not addressed in this study. 
 
9. CONCLUSIONS: 
 
In supine position radiotherapy for breast cancer, a vacuum bag immobilisation device 
demonstrated equivalence to use of a breast board in terms of interfraction variability. 
The mean random error was significant lesser with a vacuum bag immobilisation 
compared to a breast breast board. Furthermore, the difference in error was 
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pronounced among overweight and obese patients with the use of a vacuum bag 
immobilisation. 
 
Eleven out of 16 patients preferred to use a vacuum bag immobilisation compared to a 
breast board immobilisation in terms of comfort. Objective assessment of comfort also 
showed correlation with patients’ preference for vacuum bag immobilisation.  
 
The mean setup duration was a minute lesser with the use of a vacuum bag 
immobilisation compared to a breast board and the difference was statistically 
significant. The mean treatment time and mean in room time were also lesser with the 
use of a vacuum bag immobilisation. 
 
The quality of plans were similar and the planning objectives were also achieved with 
same ease across both the devices. 
 
10. CONCLUDING REMARK: 
 
Vacuum bag immobilisation can be used as a valid alternative to breast board 
immobilisation in supine position radiotherapy for breast cancer. Vacuum bag 
immobilisation may be preferred over use of breast board among overweight and 
obese patients. 
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12. APPENDIX: 
12.1 PATIENT INFORMATION SHEET AND CONSENT FORMS: 
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மற்=ம் சCகரியம் Eன்னிட்L நாங்கள் சாதனங்கள் பயன்பLத்*0ேறாம். இைவ  
கPரியக்கச்் ்் ்்  ்N0சை்ச்்்  Eடக்க்்் ச்் ் ்சாதனங்கள்் ்் ்் ்  என Kறப்பL0ற*.  
ெபா*வாக மாரப்க Vற்=ேநாய் N0சை்ச8ல் மாரப்க பலைக எWம் காரப்ன் ஃைபபர ்
பலைக உபேயாகப்பLத்தப்பLத்*ேவாம்.  ஒேர வைகயான பலைக எல்லா 
ேநாயாளிக-க்.ம் அவரக்ளின் அளC மற்=ம் வ3வம் க(த்Pல் ெகாள்ளாமல் 
பயன்பLத்தப்பL0ற*.  
இதற். மாற்றாக ”ெவற்Fடப் ைப” என்Wம் மற்ெறா( மாற்= சாதனம் மற்ற இடங்களில் 
பயன்பாட்3ல் உள்ள*.  இ* நீங்கள் உங்க-க். என்ேற தனிப்பட்ட Eைற8ல், கPரியக்க  
ெதாடர ்N0சை்ச8ல் இ(ந்தால் மட்Lேம சாத்Pயம்.  
இங். உங்கள் CMC ல்  !ற்$ேநாய் *+சை்செப$ேவா1க்3 ஏற்ற %கசச்ரியான ஒ. 
நிைலப3த்5தல் 6டக்கச ்சாதனம் நி9:தல் ெதாடரப்்பான ஆய்: நாங்கள் ேமற்ெகாண்3 
வ.Bேறாம். நீங்கள்  இந்த ஆராய்சF் Gட்டத்Gன் ஒ. பHGயாக இ.க்க ேவண்3ம் 
அைழக்Bேறாம். நீங்கள் இந்த நல்ல  ேநாக்கத்Gற்கான ஆராய்சF்Kன் ஒ. பHGயாக 
ஒப்Lக்ெகாள்Mம் பட்சத்Gல் நீங்கள் மாரப்க பலைக அல்ல5 ெவற்Nடப்ைப 6ைறKல் ஒ. 
நாள் Oட்3 ஒ. நாள் கGரP்சQ் ெப9ம்  நபராக  இ.க்க ேவண்3ம்.  நாங்கள்  கGரியக்கம் 
அேத அள:,  Gனசரி,  அேத இடத்Gல் உடம்Tற்Hள் ெசல்Bற5 என்9 உ9G ெசய்ேவாம். 
5ல்Vயம் சரிபாரக்்க ஒவ்ெவா. கGரியக்க அமரO்ற்H 6ன்Lம் FBசை்ச எந்Gரத்Gன் ேமல்  
F.W. ஸ்ேகன் ெசய்5 உ9G ப3த்தப3ம். இ5 கGரியக்க  FBசை்ச 5ல்Vயமாக இ.க்க 
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ேமற்ெகாள்Mம் ஒ. வழக்கமான நைட6ைறயாHம்.   ேமYம் இ5 வழக்கமான கGரியக்க 
FBசை்சைய Oட எந்த அGக ஆபத்ைதZம் ஏறப3த்தா5. 
இந்த ஆராய்சF்Kன் பHGயாக, ம.த்5வர ்உங்கள் ெபா5 தகவல் மற்9ம் உயரம் எைட 
ேபான்றைவ உட்பட உடல் அள:.க்கள் ேசகரித்தல் மற்9ம் F.W. ஸ்ேகன் இல் காணப்ப3ம் 
Gனசரி அைமப்L மாற்றங்கள் இவற்ைற FBசை்சக்H 6ன்பாக பG: ெசய்வார.் 6[ 
FBசை்ச ெசய்Zம் ேபா5 நான்H 6ைற F.W. ஸ்ேகன் ஒ. FBசை்ச 6Wந்த:டன் FBசை்ச  
பHGகMக்H இைடேய எ3க்கப்ப3ம். இந்த FBசை்சKன் ேபா5 நீங்கள் எந்த அள: 6ன் 
ெசன்9 உள்ளீரக்ள் என்பைத பாரக்்க இ5 அவFயம். இந்த ஆய்Oன் ேபா5 நீங்கள் எந்த 
ெசல:கMம் ெசய்ய ேவண்W வரா5, மாறாக உங்களின் தரமான FBசை்சKன் ஒ. 
சரிபாரப்்L பHGயாக அ5 நன்ைம பயக்Hம் 
ஆய்Oன் ஒ. பHGயாக நீங்கள் இந்த இரண்3 6டக்கச ்சாதனங்கைள பயன்ப3த்5வ5 
HNத்5  உங்கள் Lரிதல் மற்9ம் ச:கரிய நிைல பற்Nய ஒ. ேகள்Oத்தாைள 
நிரப்Tத்த.மா9 ேகட்கப்படலாம். 
உங்கள் ெபயர ்எந்த அNOயல் மற்9ம் 5ைற சாரந்்த ெவளி\3களில் பயன்ப3த்தப்பட 
மாட்டா5.  ேசகரிக்கப்பட்ட தகவல்கள் மட்3ேம தங்கள் ரகFயம் காக்கப்பட்3 அNOயல் 
ேமைடகள் மற்9ம் ம.த்5வ ஆய்வரங்கங்களில் பயன்ப3த்தப்ப3ம். உங்கள் பங்ேகற்L 
இந்த 6யற்FKல் உங்கள் பங்ேகற்L எGரக்ால ேநாயாளிகMக்H ஒ. Fறந்த 6டக்கச ்
சாதன  மாற்Nற்H பயனாகலாம்.  
 
2ல ெபா%வான ேகள்%கள் மற்(ம் உங்கள் கவன-ற்காக 0ல தகவல்கள் : 
க-ரியக்க 07சை்ச என்றால் என்ன? 
க"ரியக்கச ்ஊ*க"ரக்ள் (எக்ஸ் க"ரக்ள்) 0லம் 3ற்5ேநாய்கான :;சை்ச =ைறயா>ம். 
நீங்கள் க"ரB்சC் ேமற்ெகாள்Eம் ேபாG நீங்கள் உணரJ்ம் இLக்காG. அG வOயற்றG.  
ஆQன் நீங்கள் 15 நிTடங்கள் அைசயாமல் ப*த்"Lக்க பரிந்Gைரக்கப்ப*Bரக்ள்.  
IMRT என்றால்் ்் ்் ்  என்ன்்்  ? 
IMRT என்பG 3ற்5 ேநாய் கட்\ ப>" த]ரத்்G  மற்ற "Cக்களில் க"ரியக்க அளJகள் 
>ைறத்G Gல்Oயமான :;சை்ச தLம் நBன கணினி ெதா^ல் _ட்பம் ஆ>ம். 
 
எப்ப\்்்  மாரப்க்்்  3ற்5்்்  ேநாய்க்>் ்் ்் ்  க"ரியக்க்்்  :;சை்ச்்்  உதJம்்்்? 
மாரப்க 3ற்5 ேநாயாளிகEக்> அ5ைவ :;சை்சக்> `ற> க"ரியக்கச ்:;சை்ச 
ெகா*க்கப்பட்ட ேபாG உள்ளாக ேநாைய >ணப்ப*த்Gவ"ல் உதJ;றG. இG மாரப்க 
3ற்5ேநாய் :;சை்ச ெபற்ற ேநாயாளிகEக்> ஆaைள அ"கரிக்;றG. 
 
க"ர்்் ்Bச்்்:்ன்்்் பக்க்்்  ]ைளJகள்்்் என்ன்்் ? 
இைவ நீங்கள் :;சை்ச ேமற்ெகாள்Eம்ேபாG ஏற்ப*ம் உடன\ ]ைளJகள், மற்5ம் 
:;சை்ச  =\ந்தJடன் காலம் கடந்G ஏற்ப*ம் `ன் ]ைளJகள் ஆ;யைவ அடங்>ம். 
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உடன\ அல்லG க*ைமயான ]ைளJகள் க"ரB்ச:்ன் `ராந்"யத்"ன் ேமல் ேதால் 
கLைம அைடaம் மற்5ம் 3ண்கEம் ஏற்ப*ம். 
தாமதமாக பக்க ]ைளJகளாவன :  தைச ]ைறப்3, இதய `ரச:்ைனகள் (கேரானரி இதய 
ேநாய், தைசேநாய் தைல மாரப்க 3ற்5ேநாய் ேநாயாளிகEக்>) மற்5ம் Cவாச 
`ரச:்ைனகள் ஆ;யைவ அடங்>ம். 
 
இந்த ஆய். எதற்காக? 
இந்த ஆய்2 மாரப்க 6ற்7 ேநாய்க்ெக(ரான நம- ./சை்ச2ல் பயன் ப5த்தப்ப5ம் 
.றந்த க"ரியக்கச்் ்் ்்  ்:;சை்ச்்்  =டக்க்்்  நிைலச்்் ்சாதனங்கள்் ்் ்் ்  கண்567க்3ம் ேநாக்க9ல் 
நடத்தப்ப5வ=. 
 
இந்த ஆய்$ல் &'சை்ச*ல் ேவ-பா0 உண்டா? 
>+சை்ச ம1ந்= அல்ல= காலம் '(த்* எந்த -த்.யாச1ம் இல்ைல.  நிைலயான 
67சை்ச ெந(1ைற ெதாடரந்்* கைட<=த்* வரப்ப@ம். ஒேர ஒD -த்.யாசம் 
67சை்சக்'ப் பயன்ப@த்தப்ப@ம் க.ரியக்கச்் ்் ்்  ் 12சை்ச்்்  3டக்க்்் ச்் ் ் சாதனங்கள்் ்் ்் ்  மாற்றம் 
ஆ&ம். 
இ"ல்்்் நான்்்் பங்ெக&த்தால்் ் ்் ் ்் ் ்  அ,க பக்க்்்  -ைள0கள்்்் சந்,க்க் ்் ்் ்  ேநரி&மா ? 
ெமாத்த க,ர8்ச9் அள8& மற்;ம் 9ற்<=ள்ள கட்டைமப்?கள் ஆAயைவ ஒE தரமான 
நிைலயான Gபாரி9 அள0கள் மட்&ேம கைடHIக்கப்ப&ம். எனேவ நாம் எந்த L&தல் 
பக்க -ைள0கள் எ,ரப்ாரக்்க ேவண்டாம். 
 
 
27சை்ச காரணமாக நீங்கள் 2ல பக்க $ைள'கைள சந்*த்தால் என்ன நடக்2ம்?  
க9ரியக்க 67சை்சEல் ஏற்ப@ம் வழக்கமான பக்க 8ைள:கள் த)ர ேவ< எந்த 
காயேமா ஊேறா எ"ரப்ாரக்்கப்பட)ல்ைல. ஆனால் நீங்கள்  ஆய்5 
காரணமாக  பக்க)ைள58ரச:்ைனகள் உ<வா>னால்  ெசல)ன்@ :>சை்ச 
ெசய்Aெகாள்ளலாம். இA த)ர யா<க்Dம் எந்த பண இழப்FG வழங்க HIயாமல் 
இ<க்>ேறாம்.  
 
இந்த ஆய்$ல் எந்த *ள்ளி-ல் இ/ந்0ம் 2/ம்பப் ெபற 678மா? 
இந்த ஆய்8ல் உங்கள் பங்களிப்5 !ற்$%ம் தன்னாரவ்மானேத. மற்/ம் நீங்கள் இந்த 
ஆய்8ல் பங்ேகற்;ம் அ=ம>ைய எப்ேபாA ேவண்Cமானா%ம் >Dம்பப் ெபறலாம். 
நீங்கள் இவ்வா/ ெசய்தால், இA எந்த வHI%ம் இந்த மDத்AவமைனIல் உங்கள் 
வழக்கமான LMசை்சைய பா>க்காA. ஆய்N நடவPக்ைகIல் இDந்A >Dம்பப் ெபற்/க் 
ெகாண்டQன், நீங்கள் 8Dம்Rம் க.ரியக்கச்் ்் ்்  ் 12சை்ச்்்  3டக்க்்் ச்் ் ் சாதனம்்்் பயன்ப7த்.் ்் ்் ்  
உங்கள் ./சை்ச ெதாடரலாம். 
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ம)த்*வப் பரிேசாதைன3ல் கலந்* ெகாள்ள  
ஒப்9தல் அ;க்ைக 
ஓ8 உள்ளைமந்த +ைற சாரந்்த ஆய்2 – மாரப்க 6ற்7 ேநாய்க்9 எ;ரான க;ரியக்க 
>?சை்ச – மாரப்க பலைக நிைலப்பCைக* மற்7ம் வாக்லாக் நிைலபCைக ெதாடரப்ான 
ஆய்3 : <ல்=யம், >?சை்ச ேநரம் மற்Dம் ேநாயாளிMன் ச2கரியம்  
ஆய்< எண் : RT11502 
பங்ேகற்பவரின் ெபயர் :  
Eறந்த நாள் / வய) (வ+டத்.ல்) :  
நான் _______________________________________________________________________________ தந்ைத / கணவர ்
ெபயர ்___________________________________________  இதன் Sலம் அG/ப்ப< :  
ெபட்U:ல் ”Uக்” ெசய்ய%ம் :  
[          ]   இந்த ஆய்% ெதாடரப்ான எனக்6 வழங்கப்பட்ட தகவல் ைகேயடை்ட ப=த்> 
?ரிந்> ெகாண்B என் சந்ேதகங்கைளDம் ெதளி%பBத்Eக்ெகாண்ேடன் 
[          ]   நான் இந்த ஆய்Fல் என் பங்6 Gற்IJம் தன்னாரவ்  ேநாக்Kல் ஆன> 
என்Lம், என் வழக்கமான NKசை்ச அல்ல> என் சட்டரீEயான உரிைமகைள பாEக்காத 
வைகRல் மற்Lம் எந்த ேநரத்EJம் இந்த அSமEைய ETம்பப்ெபறலாம் என்பைதDம் 
ெதரிந்>ள்ேளன்.  
[          ]   நான் இந்த ஆய்% சம்மந்தமாக காயம் அல்ல> Vங்6 FைளFக்6ம் நிகழ்%  
ேநரி=ன் இலவச NKசை்ச அளிக்கப்பBம் என்ப>ம் மற்றப= Wற நிE இழப்XB வழங்கப் 
பட மாட்டா> என்ப>ம்  ?ரிந்> ெகாண்ேடன்.  
[          ]   இந்த ஆய்Fல் சம்பந்தப்பட்ட ஊZயரக்ள் மற்Lம் நிLவன ெநIGைறகள் 
6[ உLப்Wனரக்ள் என் மTத்>வப் பE%கைள பாரக்்க என் அSமE ேதைவRல்ைல.நான் 
இைத அ\க ஒப்?க்ெகாள்Kேறன் 
        
[          ]   என் தனிப்பட்ட அைடயாளத்ைத எந்த வைகRJம் ^ன்றாவ>  நபTக்6 
ெவளிRடப்பட மாட்டா> என்L ?ரிந்> ெகாண்ேடன்.  
[          ]   நான் தன்னிசை்சயாக இந்த் ஆய்Fல் பங்6 ெபற சம்மEக்Kேறன்.   
 
ெபயர ்     சாட்NRன் ெபயர ்
ைகெயாப்பம்    பங்6ெபLபவTக்6ம் சாட்Nக்6மான உற% 
 
நாள் :       சாட்NRன் ைகெயாப்பம்      
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12.2 DATA FORMS: 
 
Chris&an	Medical	College,	Vellore  
Department	of	Radiotherapy
A	WITHIN	SUBJECT	STUDY	COMPARING	BREAST	BOARD	IMMOBILISATION	
WITH	VACLOC	IMMOBILISATION	FOR	RADIOTHERAPY	IN	BREAST	CANCER:	
SETUP	PRECISION,	TREATMENT	TIME	AND	PATIENT	COMFORT	
DAY 14 QUESTIONNAIRE DAY 15 QUESTIONNAIRE
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!Name!of!the!patient:!!Age:!! ! ! ! ! ! ! Gender:!Height:!! ! ! Weight:! ! ! BMI!:!Chest!circumference!:! ! ! ! Breast!Cup!size:!Address:!! ! ! ! ! ! Care!of:!
Nearest!contact!phone/!email:!! ! Occupation:!
Hospital!Number:!!! ! ! ! RT!No:!
Disease&information:&&Histology:  Biopsy!number!and!report:!
A"WITHIN"SUBJECT"STUDY"COMPARING"BREAST"BOARD"IMMOBILISATION"WITH"VACLOC"
IMMOBILISATION"FOR"RADIOTHERAPY"IN"BREAST"CANCER:"SETUP"PRECISION,"
TREATMENT"TIME"AND"PATIENT"COMFORT"
Chris>an"Medical"College,"Vellore  
Department"of"Radiotherapy
Pa>ent"data"sheet
RT11502
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12.3 QUESTIONNAIRE: 
Date__________________ 
Hospital #________________        
Study Number: RT11502 
Radiation Therapy Immobilisation – Comfort Questionnaire 
Below are statements that may describe your comfort now.  Six numbers are provided for each question; please 
circle the number you think most closely matches your feeling.  Relate these questions to your comfort at the 
moment you are answering the questions.  
 
 
 
1. My body feels relaxed 
2. I feel comfortable in this position 
3. Pain in my shoulder bothers me 
4. It feels embarrassing to lie in this position 
5. My back muscles ache when i lie on  
6. I feel dependant on others 
Strongly 
agree
Strongly 
disagreeQuestions
6 5 4 3 2 1
6 5 4 3 2 1
6 5 4 3 2 1
6 5 4 3 2 1
6 5 4 3 2 1
6 5 4 3 2 1
Questionnaire
Circle either of the following 
I prefer and i feel comfortable when i use 
VACLOC BREAST BOARD 
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12.4 MASTER DATA: 
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